Samsung Bioepis And Sandoz Get EU Nod For Stelara Rival
CHMP Positive Opinion Issued For Pyzchiva Ustekinumab Biosimilar And Accord Generics
Samsung Bioepis has received an EMA nod for its Sandoz-partnered Stelara biosimilar under the name Pyzchiva. Meanwhile, the agency’s CHMP also recommended granting centralized marketing authorizations for two Accord generics.
